000891082 001__ 891082
000891082 005__ 20220930130310.0
000891082 0247_ $$2doi$$a10.3390/ph14030277
000891082 0247_ $$2Handle$$a2128/27460
000891082 0247_ $$2pmid$$a33803861
000891082 0247_ $$2WOS$$aWOS:000634083300001
000891082 0247_ $$2altmetric$$aaltmetric:103044477
000891082 037__ $$aFZJ-2021-01353
000891082 082__ $$a610
000891082 1001_ $$0P:(DE-Juel1)156407$$aSchneider, Daniela$$b0$$eCorresponding author
000891082 245__ $$aSpecies Differences in Microsomal Metabolism of Xanthine-Derived A1 Adenosine Receptor Ligands
000891082 260__ $$aBasel$$bMDPI$$c2021
000891082 3367_ $$2DRIVER$$aarticle
000891082 3367_ $$2DataCite$$aOutput Types/Journal article
000891082 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1616492493_27007
000891082 3367_ $$2BibTeX$$aARTICLE
000891082 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000891082 3367_ $$00$$2EndNote$$aJournal Article
000891082 520__ $$aTracer development for positron emission tomography (PET) requires thorough evaluation of pharmacokinetics, metabolism, and dosimetry of candidate radioligands in preclinical animal studies. Since variations in pharmacokinetics and metabolism of a compound occur in different species, careful selection of a suitable model species is mandatory to obtain valid data. This study focuses on species differences in the in vitro metabolism of three xanthine-derived ligands for the A1 adenosine receptor (A1AR), which, in their 18F-labeled form, can be used to image A1AR via PET. In vitro intrinsic clearance and metabolite profiles of 8-cyclopentyl-3-(3-fluoropropyl)-1-propylxanthine (CPFPX), an established A1AR-ligand, and two novel analogs, 8-cyclobutyl-3-(3-fluoropropyl)-1-propylxanthine (CBX) and 3-(3-fluoropropyl)-8-(1-methylcyclobutyl)-1-propylxanthine (MCBX), were determined in liver microsomes from humans and preclinical animal species. Molecular mechanisms leading to significant differences between human and animal metabolite profiles were also examined. The results revealed significant species differences regarding qualitative and quantitative aspects of microsomal metabolism. None of the tested animal species fully matched human microsomal metabolism of the three A1AR ligands. In conclusion, preclinical evaluation of xanthine-derived A1AR ligands should employ at least two animal species, preferably rodent and dog, to predict in vivo behavior in humans. Surprisingly, rhesus macaques appear unsuitable due to large differences in metabolic activity towards the test compounds.
000891082 536__ $$0G:(DE-HGF)POF4-525$$a525 - Decoding Brain Organization and Dysfunction (POF4-525)$$cPOF4-525$$fPOF IV$$x0
000891082 588__ $$aDataset connected to CrossRef
000891082 7001_ $$0P:(DE-Juel1)131810$$aBier, Dirk$$b1
000891082 7001_ $$0P:(DE-Juel1)131824$$aHolschbach, Marcus$$b2$$ufzj
000891082 7001_ $$0P:(DE-Juel1)131672$$aBauer, Andreas$$b3$$ufzj
000891082 7001_ $$0P:(DE-Juel1)166419$$aNeumaier, Bernd$$b4
000891082 773__ $$0PERI:(DE-600)2193542-7$$a10.3390/ph14030277$$gVol. 14, no. 3, p. 277 -$$n3$$p277 -$$tPharmaceuticals$$v14$$x1424-8247$$y2021
000891082 8564_ $$uhttps://juser.fz-juelich.de/record/891082/files/Invoice_MDPI_pharmaceuticals-1137340_1379.12EUR.pdf
000891082 8564_ $$uhttps://juser.fz-juelich.de/record/891082/files/pharmaceuticals-14-00277.pdf$$yOpenAccess
000891082 8767_ $$8pharmaceuticals-1137340$$92021-03-15$$d2021-03-17$$eAPC$$jZahlung erfolgt$$ppharmaceuticals-1137340$$zBelegnr. 1200164893 / 2021
000891082 909CO $$ooai:juser.fz-juelich.de:891082$$popenCost$$pVDB$$pdriver$$pOpenAPC$$popen_access$$popenaire$$pdnbdelivery
000891082 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)156407$$aForschungszentrum Jülich$$b0$$kFZJ
000891082 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131810$$aForschungszentrum Jülich$$b1$$kFZJ
000891082 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131824$$aForschungszentrum Jülich$$b2$$kFZJ
000891082 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131672$$aForschungszentrum Jülich$$b3$$kFZJ
000891082 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)166419$$aForschungszentrum Jülich$$b4$$kFZJ
000891082 9130_ $$0G:(DE-HGF)POF3-573$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$vNeuroimaging$$x0
000891082 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
000891082 9141_ $$y2021
000891082 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2020-09-05
000891082 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2020-09-05
000891082 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2020-09-05
000891082 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000891082 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2020-09-05
000891082 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2020-09-05
000891082 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2020-09-05
000891082 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2020-09-05
000891082 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2020-09-05
000891082 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2020-09-05
000891082 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000891082 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2020-09-05
000891082 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2020-09-05
000891082 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2020-09-05
000891082 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2020-09-05
000891082 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2020-09-05
000891082 920__ $$lyes
000891082 9201_ $$0I:(DE-Juel1)INM-5-20090406$$kINM-5$$lNuklearchemie$$x0
000891082 9201_ $$0I:(DE-Juel1)INM-2-20090406$$kINM-2$$lMolekulare Organisation des Gehirns$$x1
000891082 980__ $$ajournal
000891082 980__ $$aVDB
000891082 980__ $$aUNRESTRICTED
000891082 980__ $$aI:(DE-Juel1)INM-5-20090406
000891082 980__ $$aI:(DE-Juel1)INM-2-20090406
000891082 980__ $$aAPC
000891082 9801_ $$aAPC
000891082 9801_ $$aFullTexts